Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma

By Okusaka Takuji   Okada Shuichi   Nakanishi Toshio   Fujiyama Shigetoshi   Kubo Yasuhiko  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 169-176

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of dolastatin-10 in patients with advanced breast cancer

By Perez Edith   Hillman David   Fishkin Paul   Krook James   Tan Winston   Kuriakose Phillip   Alberts Steven   Dakhil Shaker  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 257-261

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma

By Vuky Jacqueline   Isacson Christina   Fotoohi Mehran   Cruz Jason   Otero Henry   Picozzi Vincent   Malpass Thomas   Aboulafia David   Jacobs Andrew  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors

By Feldman Darren   Turkula Stefan   Ginsberg Michelle   Ishill Nicole   Patil Sujata   Carousso Maryann   Bosl George   Motzer Robert  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 523-528

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors

By Varuni Kondagunta G.   Bacik Jennifer   Schwartz Lawrence   Sheinfeld Joel   Bajorin Dean   Vuky Jacqueline   Marion Stephanie   Mazumdar Madhu   Bosl George J.   Motzer Robert J.  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 177-179

Springer Publishing Company

Access to resources Recommend Favorite